bruceine d has been researched along with bibw 2992 in 1 studies
| Studies (bruceine d) | Trials (bruceine d) | Recent Studies (post-2010) (bruceine d) | Studies (bibw 2992) | Trials (bibw 2992) | Recent Studies (post-2010) (bibw 2992) |
|---|---|---|---|---|---|
| 31 | 0 | 22 | 1,044 | 147 | 1,007 |
| Protein | Taxonomy | bruceine d (IC50) | bibw 2992 (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.0361 | |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 0.0168 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.037 | |
| Cytochrome P450 2E1 | Homo sapiens (human) | 0.014 | |
| Cytochrome P450 2C8 | Homo sapiens (human) | 0.037 | |
| Receptor tyrosine-protein kinase erbB-3 | Homo sapiens (human) | 0.0007 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.037 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.0016 | |
| Receptor tyrosine-protein kinase erbB-4 | Homo sapiens (human) | 0.0024 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, R; Han, M; Hu, Y; Wang, L; Yang, Y; Zhu, J | 1 |
1 other study(ies) available for bruceine d and bibw 2992
| Article | Year |
|---|---|
Bruceine D and afatinib combination inhibits ovarian cancer cells proliferation and migration through DNA damage repair and EGFR pathway.
Topics: Afatinib; Cell Line, Tumor; Cell Proliferation; DNA Damage; ErbB Receptors; Female; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Ovarian Neoplasms | 2023 |